×ðÁú¿­Ê±

English

×ðÁú¿­Ê±ÐÂÆ·£º¡°Î¸¡±ÄãµÄ¿µ½¡¶øÀ´

Ðû²¼ÓÚ£º2025-09-23

ÎÄÕÂȪԴ£º[ÖÐÎÄ]×ðÁú¿­Ê±ÉúÎï



¹ÙÐû

¿ËÈÕ£¬×ðÁú¿­Ê±ÉúÎï×ÔÖ÷Ñз¢µÄθÃÚËØ17£¨G-17£©»¯Ñ§·¢¹â¼ì²âÊÔ¼ÁºÐ£¬
Õýʽ»ñµÃ±±¾©ÊÐÒ©Æ·¼àÊÓÖÎÀí¾Ö½ÒÏþµÄÒ½ÁÆÆ÷еע²áÖ¤£¡Õâ±ê¼Ç×Å×ðÁú¿­Ê±ÉúÎïÔÚθ¹¦Ð§¼°Ïà¹Ø¼²²¡¼ì²âÁìÓòÈ¡µÃÁËÍ»ÆÆÐÔÏ£Íû¡£



θÃÚËØ£¨Gastrin£©ÊÇÒ»ÖÖÖ÷ÒªÓÉθñ¼ºÍÊ®¶þÖ¸³¦£Çϸ°ûÉøÍ¸µÄ賦¼¤ËØ£¬¶Ôµ÷ÖÎÏû»¯µÀ¹¦Ð§ºÍά³ÖÆä½á¹¹ÍêÕûÓÐÖ÷Òª×÷Óá£ÈËÌåÖÐ95£¥ÒÔÉÏÓÐÉúÎï»îÐÔµÄθÃÚËØÊǦÁ-õ£°·»¯Î¸ÃÚËØ£¬Ö÷Òªº¬Á½ÖÖÒì¹¹ÌåG-17ºÍG-34£¬ÆäÖÐ80%~90%ÊÇG-17¡£G-17½öÓÉθñ¼²¿Gϸ°ûÉøÍ¸£¬Òò´ËG-17ÊÇ·´Ó¦Î¸ð¤Ä¤ËðÉËÇéÐεÄÖ÷ÒªÖ¸±ê¡£


G-17µÄÐÄÀí¹¦Ð§


01

´Ì¼¤Î¸ËáÉøÍ¸£ºG-17¿ÉÒÔ×÷ÓÃÓÚθ±Úϸ°û£¬Ôö½øÆäÉøÍ¸ÑÎËᣨHCl£©£¬´Ó¶øÔöǿθµÄÏû»¯¹¦Ð§£¬ÓÐÖúÓÚʳÎïµÄÏû»¯ºÍÎüÊÕ¡£

02

Ôö½øÎ¸ð¤Ä¤Éú³¤ºÍÐÞ¸´£ºG-17Äܴ̼¤Î¸ð¤Ä¤Ï¸°ûµÄÔöÖ³ºÍ·Ö½â£¬Î¬³Öθð¤Ä¤µÄÍêÕûÐÔ£¬¶Ôθð¤Ä¤Æðµ½±£»¤ºÍÐÞ¸´×÷Óá£Õâ¹ØÓÚµÖÓùθËᡢθÂѰ×øµÈ¶Ôθð¤Ä¤µÄËðÉËÖÁ¹ØÖ÷Òª¡£

03

µ÷Àí賦µÀÔ˶¯£ºG-17¶Ô賦µÀµÄÔ˶¯Ò²ÓÐÒ»¶¨µ÷Àí×÷Ó㬿ÉÓ°ÏìθÅſռ°³¦µÀÈ䶯µÈÀú³Ì£¬°ü¹ÜʳÎïÔÚ賦µÀÄÚÓÐÐòÍÆ½øºÍÏû»¯ÎüÊÕ¡£


G-17ÓëθËáÐγɸº·´Ïì»úÖÆ£¬Î¸ñ¼¹¦Ð§Õý³£Ê±¸Ã»úÖÆ¿Éά³ÖθËáÉøÍ¸µÄ¶¯Ì¬Æ½ºâ£»µ±Î¸ñ¼Î®Ëõʱ£¬¸Ã»úÖÆÊ§ºâ¡£


G-17µÄÁÙ´²Ó¦ÓÃ


01

θ°©ÔçÆÚɸ²é

θ²¿²¡±äΣº¦Ô¤¾¯

Õý³£ÇéÐÎÏ£¬Î¸ð¤Ä¤µÄ½á¹¹ºÍ¹¦Ð§¼á³ÖÎȹÌ£¬G-17µÄÉøÍ¸Ò²´¦ÓÚÏà¶ÔƽºâµÄ״̬¡£µ±Î¸ð¤Ä¤±¬·¢°©±äʱ£¬Î¸ñ¼²¿Gϸ°ûµÄ¹¦Ð§ºÍÂþÑܻᱬ·¢¸Ä±ä£¬½ø¶øµ¼ÖÂѪÇåÖÐG-17ˮƽ·ºÆðÒì³£²¨¶¯¡£Í¨¹ý¼ì²âѪÇåG-17ˮƽ£¬ÄÜÔÚÒ»¶¨Ë®Æ½ÉÏÌáÐÑθ²¿ÊÇ·ñ±£´æ²¡±äÒÔ¼°°©±äµÄΣº¦¡£

ÍŽáɸ²éÖ¸±ê

ÔÚÏÖʵӦÓÃÖУ¬Í¨³£½«ÑªÇåG-17ÓëθÂѰ×øԭ£¨PG£©¡¢ÓÄÃÅÂݸ˾ú£¨Hp£©¿¹Ìå¼ì²âµÈÍŽáʹÓ㬹¹½¨¶àÖ¸±êµÄθ°©É¸²éϵͳ¡£ºÃ±È£¬µ±G-17ˮƽÉý¸ß£¬Í¬Ê±Î¸ÂѰ×øԭ¢ñ/¢ò±ÈÖµ½µµÍʱ£¬ÔòÌáÐÑθñ¼²¿ð¤Ä¤¿ÉÄܱ£´æ²¡±ä£¬ÐèÒª½øÒ»²½Í¨¹ýθ¾µ¼ì²éµÈÊÖ¶ÎÃ÷È·ÊÇ·ñ»¼ÓÐθ°©¡£

02

θ²¿¼²²¡Õï¶ÏÓëÅбðÕï¶Ï

ήËõÐÔθÑ×

ƾ֤ήËõ²¡±äµÄ²¿Î»²î±ð£¬G-17ˮƽת±äÒ²Óвî±ð¡£Î¸ñ¼²¿Î®Ëõʱ£¬ÓÉÓÚ±¬·¢G-17µÄGϸ°ûÊýÄ¿ïÔÌ­£¬ÑªÇåG-17ˮƽͨ³£»á½µµÍ£»¶øÎ¸Ì岿ήËõʱ£¬Î¸ËáÉøÍ¸ïÔÌ­£¬¶ÔGϸ°ûÉøÍ¸G-17µÄ¸º·´ÏìÒÖÖÆ×÷ÓÃÏ÷Èõ£¬¿Éµ¼ÖÂG-17ˮƽÉý¸ß¡£

θÃÚËØÁö

θÃÚËØÁöÊÇÒ»ÖÖÉñ¾­ÄÚÉøÍ¸Ö×Áö£¬Ö×Áöϸ°û»á´ó×Ú×ÔÖ÷ÉøÍ¸Î¸ÃÚËØ£¬µ¼ÖÂѪÇåG-17ˮƽÏÔÖøÉý¸ß£¬Áè¼Ý1000pg/mL¡£ÍŽỼÕßÖØ¸´±¬·¢µÄÏû»¯ÐÔÀ£Ññ¡¢¸¹ÐºµÈÁÙ´²Ö¢×´£¬¼ì²âG-17ˮƽÓÐÖúÓÚθÃÚËØÁöµÄÕï¶Ï¡£

03

ÆÀ¹Àθ²¿ÊÖÊõЧ¹û¼°²¡Çé¼à²â

ÊÖÊõЧ¹ûÆÀ¹À

¹ØÓÚ½ÓÊÜθ´ó²¿ÇгýÊõµÄ»¼Õߣ¬Êõºó¼à²âG-17ˮƽÄܹ»·´Ó¦Ê£Óàθñ¼²¿Gϸ°ûµÄÉøÍ¸¹¦Ð§£¬½ø¶øÆÀ¹ÀÊÖÊõ¶ÔθÄÚÉøÍ¸¹¦Ð§µÄÓ°Ïì¡£

Êõºó²¡Çé¼à²â

ÔÚθ°©µÈ¼²²¡µÄÖÎÁÆÀú³ÌÖУ¬¶¯Ì¬¼à²âG-17ˮƽ¿ÉÒÔ×ÊÖúÅжϲ¡ÇéÏ£Íû¡¢ÖÎÁÆÐ§¹ûÒÔ¼°ÊÇ·ñ¸´·¢¡£Èôθ°©»¼ÕßÔÚÊõºó»ò·Å»¯Áƺó£¬G-17ˮƽÔÙ´ÎÉý¸ß£¬¿ÉÄÜÌáÐÑÖ×Áö¸´·¢»ò×ªÒÆ£¬ÐèÒª½øÒ»²½¼ì²éºÍÖÎÁÆ¡£


×ðÁú¿­Ê±²úÆ·ÓÅÊÆ


No.1 Ñ¸Ëٶȸü¸ß

LOB¡Ü0.3 pmol/L£¬LOD¡Ü0.8 pmol/L£¬LOQ¡Ü1.0 pmol/L¡£

No.2 Ï¸ÃܶȸüÓÅ

×ܲ»Ï¸ÃܶÈCV¡Ü5%¡£

No.3 ÏßÐÔ¹æÄ£¿í

1.0-120.0 pmol/L£¬¿É±¨¸æ¹æÄ££º1.0-3840.0 pmol/L¡£

No.4 ×¼È·¶È¸ü¸ß

×ðÁú¿­Ê±ÊÔ¼ÁÓëÊг¡Ö÷Á÷±ÈÕÕÊÔ¼Á±È¶ÔÒ»ÖÂÐÔÓÅÒ죬R2£¾0.98¡£

No.5 

×ðÁú¿­Ê±¿ÉÌṩÍêÕûµÄθ¹¦Ð§¼ì²â×éºÏ£¬È«×Ô¶¯»¯ÒÇÆ÷¼ì²â£¬Öª×ãÁÙ´²ÕïÁÆÐèÇó¡£






²Î¿¼ÎÄÏ×

Schubert ML, Rehfeld JF. Gastric Peptides-Gastrin and Somatostatin. Compr Physiol. 2019;10(1):197-228. Published 2019 Dec 18. doi:10.1002/cphy.c180035



END

ÎÄÕÂȪԴ£º×ðÁú¿­Ê±ÉúÎï

Ôð±à£ºEcho

У¶Ô£ºTao¡¢Pretty




 
ÍøÕ¾µØÍ¼